American Oncology Network, Inc. Class A Common Stock
AONC
AONC was delisted on the 7th of June, 2024.
71 hedge funds and large institutions have $279M invested in American Oncology Network, Inc. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 5 reducing their positions, and 3 closing their positions.
320% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 5
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
8% more funds holding
Funds holding: 66 → 71 (+5)
7% more capital invested
Capital invested by funds: $262M → $279M (+$17.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MMA
Mizuho Markets Americas
New York
|
+$8.51M |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$5.92M |
| 3 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$3.35M |
| 4 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$2.74M |
| 5 |
BHMP
Bardin Hill Management Partners
New York
|
+$1.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$8.24M |
| 2 |
AC
Athanor Capital
New York
|
-$2.11M |
| 3 |
KCM
Kawa Capital Management
Hallandale Beach,
Florida
|
-$1.08M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$978K |
| 5 |
SRF
Silver Rock Financial
Los Angeles,
California
|
-$489K |
AONC Hedge Fund Activity: Q2 2022 in Review
71 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q2 2022, worth a combined $279M — up 6.5% from $262M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new AONC positions and 3 closed out — a net gain of 5 holders — while 21 added to existing stakes and 5 trimmed.
The largest buyer was Mizuho Markets Americas, opening a new position worth an estimated $8.51M. The largest seller was D.E. Shaw & Co, cutting an estimated $8.24M.
- 71 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q2 2022, up from 66 in Q1 2022.
- Funds reported $279M of American Oncology Network, Inc. Class A Common Stock stock for Q2 2022, up 6.5% quarter-over-quarter.
- 8 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q2 2022 and 3 closed out, a net change of +5 holders.
- The largest American Oncology Network, Inc. Class A Common Stock buyer in Q2 2022 was Mizuho Markets Americas, an estimated $8.51M added.
- The largest American Oncology Network, Inc. Class A Common Stock seller in Q2 2022 was D.E. Shaw & Co, an estimated $8.24M sold.
Based on aggregated 13F filings for Q2 2022.